默沙东(MRK)股吧_默沙东怎么样_分析讨论社区

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
31	0	Statement of changes in beneficial ownership of securities	默沙东资讯	07-03 12:33
26	0	Statement of changes in beneficial ownership of securities	默沙东资讯	07-03 12:32
28	0	Statement of changes in beneficial ownership of securities	默沙东资讯	07-03 12:32
53	0	虽然这波默沙东是纯蹭国内的信达和康方，但你不可否认人家就是涨了。毕竟代理费也是费	烟酒疗心殇	07-02 07:46
32	0	Annual report of employee stock purchase, savings and similar plans	默沙东资讯	06-28 02:19
31	0	Annual report of employee stock purchase, savings and similar plans	默沙东资讯	06-28 02:16
30	0	Annual report of employee stock purchase, savings and similar plans	默沙东资讯	06-28 02:13
3669	6	解读全球制药企业50强榜单：中国创新药企距离“Big Pharma”还有多远	百济神州资讯	06-26 08:08
747	8	推断万泰生物疫苗卖不出去的原因是，默沙东疫苗卖不出去了。默沙东21年九价净利润最	hao123hkc	06-25 08:36
1625	1	59亿眩晕药市场生变!普瑞药业杀入倍他司汀赛道，13家企业抢滩注射液市场	摩熵医药	06-25 06:04
592	0	默沙东(MRK.US)创新CMV预防药物普瑞明两种剂型在中国境内获批用于儿童患者	智通财经	06-23 09:16
294	0	默沙东：创新CMV预防药物普瑞明两种剂型在中国境内获批用于儿童患者	默沙东资讯	06-23 09:14
1477	0	和铂、百奥赛图专利纠纷升级；荣昌生物泰它西普获欧盟孤儿药资格认定｜医药早参	和铂医药-B资讯	06-18 08:04
4555	4	世卫指南“催热”中国RSV免疫赛道：赛诺菲抢滩默沙东再次冲击上市本土多路径并进	赛诺菲资讯	06-17 05:45
546	0	武田中国总裁单国洪月底离职跨国药企高管变动频繁	百济神州-U资讯	06-17 03:06
661	0	默沙东(MRK.US)长效RSV单抗在中国拟纳入优先审评	智通财经	06-17 02:55
194	0	默沙东PD-1抑制剂帕博利珠单抗新适应症获批!肝癌治疗迎来“联用”新曙光	摩熵医药	06-17 02:29
308	0	默沙东PD-1抑制剂帕博利珠单抗联合疗法获NMPA批准	默沙东资讯	06-13 05:15
711	0	默沙东(MRK.US)的帕博利珠单抗获批成为HNSCC首个围手术期治疗药物	智通财经	06-13 04:46
294	0	默沙东产品在华获批治疗不可切除的非转移性肝细胞癌	默沙东资讯	06-13 10:47
264	0	默沙东：帕博利珠单抗与仑伐替尼联合TACE新适应症在华获批	默沙东资讯	06-13 10:36
424	1	默沙东宣布全球首个口服PCSK9抑制剂三期临床试验成功	默沙东资讯	06-10 08:06
479	0	默沙东K药皮下注射剂在华申报上市，全球年销72亿美元	摩熵医药	06-10 06:01
1832	0	HPV疫苗市场争夺战升级：二价失宠，国产九价获批，千亿蛋糕如何切割？	万泰生物资讯	06-04 04:17
132	0	Statement of changes in beneficial ownership of securities	默沙东资讯	06-04 01:48
59	0	Statement of changes in beneficial ownership of securities	默沙东资讯	06-04 01:28
80	0	Statement of changes in beneficial ownership of securities	默沙东资讯	06-04 01:26
60	0	Statement of changes in beneficial ownership of securities	默沙东资讯	06-04 01:23
61	0	Statement of changes in beneficial ownership of securities	默沙东资讯	06-04 01:20
46	0	Statement of changes in beneficial ownership of securities	默沙东资讯	06-04 01:16
47	0	Statement of changes in beneficial ownership of securities	默沙东资讯	06-04 01:08
45	0	Statement of changes in beneficial ownership of securities	默沙东资讯	06-04 01:08
36	0	Statement of changes in beneficial ownership of securities	默沙东资讯	06-04 01:08
47	0	Statement of changes in beneficial ownership of securities	默沙东资讯	06-04 01:08
38	0	Statement of changes in beneficial ownership of securities	默沙东资讯	06-04 01:08
44	0	Statement of changes in beneficial ownership of securities	默沙东资讯	06-04 01:08
51	0	Specialized disclosure report	默沙东资讯	05-30 09:59
11616	9	多款罕见病药物国内获批 “小众药物”如何实现更大可及性？	默沙东资讯	05-27 07:41
3636	9	毕井泉被查；默沙东中国换帅丨医药早参	默沙东资讯	05-30 08:00
391	0	默沙东中国区换帅，将由现日本区总裁接任	默沙东资讯	05-30 10:34
65	0	Current report, item 5.07	默沙东资讯	05-30 01:53
342	0	默沙东回应中国总裁换人：Kyle Tattle接任田安娜将担任人类健康事业部重要职位	默沙东资讯	05-30 12:00
312	0	默沙东中国换帅：田安娜转型卸任，日本总裁接任	默沙东资讯	05-29 10:52
341	0	默沙东中国换帅：田安娜转型，日本总裁Kyle Tattle接棒	默沙东资讯	05-29 08:41
318	0	默沙东中国总裁田安娜卸任	默沙东资讯	05-29 05:54
14730	17	创新药再迎重要催化!顶级肿瘤学年会召开在即这些中国企业将参展	默沙东资讯	05-27 12:58
1091	1	药企再迎赴港上市潮：托底未盈利创新，国际化跳板加速出海	恒瑞医药资讯	05-27 08:01
331	0	默克将在ASCO2025年会上展示晚期癌症和罕见肿瘤领域创新进展	默沙东资讯	05-27 03:41
308	0	默沙东将在2025ASCO年会上发布多项研究数据	默沙东资讯	05-27 01:53
275	0	GLP-1减肥药价格战初现端倪!司美格鲁肽专利到期倒计时，中外药企加速 “拼刺刀”	恒生医疗ETF	05-23 04:05
495	0	默沙东罕见病治疗药物贝组替凡片正式在中国境内上市	默沙东资讯	05-23 01:42
255	0	默沙东HIF-2α抑制剂维利瑞（贝组替凡片）在中国境内商业上市	默沙东资讯	05-22 04:22
2479	14	默沙东九价HPV疫苗男性适应症国内上市能否提振中国市场业绩？	默沙东资讯	04-14 06:45
1669	2	超越默沙东K药，司美格鲁肽一季度登顶全球“药王”，礼来在美处方量超诺和诺德	礼来资讯	05-09 05:02
4135	5	美股成交额前20：特斯拉大涨9.8% 美国拟放松自动驾驶监管	特斯拉资讯	04-26 06:26
6992	8	重药控股发布整改报告；默克停止对中国地区订单收取临时附加费 \| 医药早参	重药控股资讯	05-15 07:24
72	0	Quarterly report filed by institutional managers, Holdings	默沙东资讯	05-15 04:09
348	0	实现中国本土包装首发，新型抗菌药物锐可博获批上市	默沙东资讯	05-14 05:45
2330	1	21健讯Daily \| 黑龙江八部门联合治理“神医”广告乱象；替尔泊肽“头对头”完胜司美格鲁肽	默沙东资讯	05-13 07:17
217	0	美股沙默东大涨，明天科伦也会一飞升天!	股友q329Q03516	05-12 09:53
315	0	默沙东新型抗菌药物锐可博（注射用亚胺西瑞）在华上市	默沙东资讯	05-12 05:38
374	0	默沙东动物保健将斥资8.95亿美元扩建美国堪萨斯州工厂	默沙东资讯	05-08 07:22
65	0	Notice of exempt solicitation submitted by non-management	默沙东资讯	05-07 07:18
451	1	罗氏制药与默克达成战略合作，推进中国肺癌精准治疗	罗氏(ADR)资讯	03-26 04:02
69	0	Statement of changes in beneficial ownership of securities	默沙东资讯	05-06 04:26
66	0	Statement of changes in beneficial ownership of securities	默沙东资讯	05-03 04:34
62	0	[Amend] Statement of changes in beneficial ownership of securities	默沙东资讯	05-03 04:33
67	0	Statement of changes in beneficial ownership of securities	默沙东资讯	05-03 04:32
59	0	Statement of changes in beneficial ownership of securities	默沙东资讯	05-03 04:32
71	0	Quarterly report [Sections 13 or 15(d)]	默沙东资讯	05-03 04:15
67	0	[Amend] Statement of changes in beneficial ownership of securities	默沙东资讯	05-03 04:08
372	1	默沙东斥资10亿美元在美国特拉华州建生产基地	默沙东资讯	04-29 07:50
81	0	Statement of changes in beneficial ownership of securities	默沙东资讯	05-02 06:22
83	0	Statement of changes in beneficial ownership of securities	默沙东资讯	05-02 06:17
95	0	Statement of changes in beneficial ownership of securities	默沙东资讯	05-02 06:16
91	0	Statement of changes in beneficial ownership of securities	默沙东资讯	05-02 06:14
109	0	Statement of changes in beneficial ownership of securities	默沙东资讯	05-02 06:12
79	0	Statement of changes in beneficial ownership of securities	默沙东资讯	05-02 06:10
93	0	Statement of changes in beneficial ownership of securities	默沙东资讯	05-02 06:08
91	0	Statement of changes in beneficial ownership of securities	默沙东资讯	05-02 06:07

emytylist

<dd id='0vfo4'></dd>